NorrChemica™
4,5-Dicyanoimidazole (DCI)
4,5-Dicyanoimidazole (DCI) | CAS 1122-28-7 | ≥97%
Couldn't load pickup availability
Technical Specifications
| CAS Number | 1122-28-7 |
| EC / EINECS Number | 214-344-6 |
| MDL Number | MFCD00005194 |
| SMILES | C1=NC(=C(N1)C#N)C#N |
| InChI | InChI=1S/C5H2N4/c6-1-4-5(2-7)9-3-8-4/h3H,(H,8,9) |
| InChIKey | XGDRLCRGKUCBQL-UHFFFAOYSA-N |
| PubChem CID | 70729 |
| Molecular Formula | C₅H₂N₄ |
| Molecular Weight | 118.1 g/mol |
| Melting Point | 168–175 °C |
| Solubility | Soluble in acetonitrile (1.8 g/10 mL, ~0.15 M; saturated ~1.1 M), DMSO, methanol |
| Log Pow | -0.85 |
| Purity | ≥97% |
| Physical Form | White to light yellow crystalline powder |
| HS Code | 2933.29 |
| Shelf Life | Retest period: 36 months from date of manufacture |
| Storage Conditions | Store in a cool, dry place in a tightly sealed container, protected from light |
Product Description & Scientific Applications
4,5-Dicyanoimidazole (DCI; 1H-imidazole-4,5-dicarbonitrile) is a heterocyclic activator for nucleoside phosphoramidite coupling in solid-phase oligonucleotide synthesis and one of the best-established alternatives to 1H-tetrazole. With a pKa of about 5.2, DCI is less acidic than tetrazole yet more nucleophilic, shifting activator design away from simple protonation strength and toward faster nucleophilic displacement during phosphoramidite activation. In the original comparative study, DCI gave complete coupling in roughly half the time required with 1H-tetrazole. DCI dissolves in acetonitrile up to about 1.1 M at room temperature and can serve as the sole coupling activator in routine automated solid-phase oligonucleotide synthesis.
Phosphoramidite activation in oligonucleotide synthesis
DCI activates nucleoside phosphoramidite coupling to the 5'-hydroxyl group during automated solid-phase synthesis. Its lower acidity is useful where acid-promoted side reactions such as double addition are a concern, while its higher nucleophilicity supports rapid and efficient coupling. This is especially useful in scale-up work, where faster activation can help reduce phosphoramidite excess relative to tetrazole-based protocols. DCI is used with standard phosphoramidite monomers in automated oligonucleotide synthesis.
Modified-oligonucleotide synthesis
DCI has been used for the synthesis of modified oligonucleotides, including 2'-O-methoxyethyl phosphorothioate sequences used in antisense research. Studies comparing DCI- and tetrazole-activated couplings of these modified phosphorothioate oligonucleotides reported equivalent synthetic and analytical outcomes, supporting DCI as a substitute for tetrazole in demanding modified-oligonucleotide work.
Non-tetrazole alternative to 1H-tetrazole
DCI is used as a non-tetrazole activator where laboratories want to avoid the explosive-handling concerns associated with 1H-tetrazole while retaining efficient phosphoramidite coupling. This makes it attractive for routine automated synthesis and scale-up work where activator handling, solubility in acetonitrile, and coupling speed are practical constraints.
Phosphitylation and phosphoramidite monomer preparation
Beyond its role as a coupling activator, DCI is used in the preparation of phosphoramidite monomers themselves. It activates phosphorodiamidite reagents for selective phosphitylation of nucleoside hydroxyl groups, supporting the synthesis of standard and non-standard phosphoramidite building blocks used in oligonucleotide assembly.
Shipping Destinations
- EU & UK only: 3–7 business days.
- UK delivered DDP — duties and taxes prepaid; CoA & SDS included.
Safety Information
| GHS Pictograms |
|
| Signal Word | Danger |
| Hazard Class | None — not subject to transport regulations |
| Transport Category | Not classified as dangerous goods for transport (ADR/IATA/IMDG) |
| H-Statements | H315 - H318 - H335 |
| P-Statements | P261 - P264 - P271 - P280 - P302+P352 - P305+P351+P338 - P310 - P332+P313 - P362+P364 - P501 |
Documentation
| Safety Data Sheet | Download PDF |
Share
